Sg Americas Securities, LLC Celldex Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,283 shares of CLDX stock, worth $622,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,283
Previous 20,316 24.45%
Holding current value
$622,214
Previous $691,000 7.53%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$23.31 - $32.4 $115,780 - $160,930
4,967 Added 24.45%
25,283 $639,000
Q3 2024

Oct 03, 2024
BUY
$32.06 - $44.56 $361,380 - $502,280
11,272 Added 124.64%
20,316 $691,000
Q2 2024

Jul 12, 2024
SELL
$32.76 - $42.56 $367,960 - $478,033
-11,232 Reduced 55.4%
9,044 $335,000
Q1 2024

May 06, 2024
SELL
$35.22 - $51.88 $908,922 - $1.34 Million
-25,807 Reduced 56.0%
20,276 $851,000
Q4 2023

Jan 12, 2024
SELL
$22.61 - $40.65 $721,892 - $1.3 Million
-31,928 Reduced 40.93%
46,083 $1.83 Million
Q3 2023

Oct 13, 2023
BUY
$25.45 - $37.46 $1.86 Million - $2.74 Million
73,079 Added 1481.73%
78,011 $2.15 Million
Q2 2023

Jul 10, 2023
SELL
$30.29 - $38.28 $165,292 - $208,893
-5,457 Reduced 52.53%
4,932 $167,000
Q1 2023

Apr 28, 2023
BUY
$34.78 - $47.43 $124,755 - $170,131
3,587 Added 52.73%
10,389 $374,000
Q4 2022

Feb 02, 2023
SELL
$27.78 - $45.38 $174,069 - $284,351
-6,266 Reduced 47.95%
6,802 $303,000
Q3 2022

Oct 31, 2022
SELL
$22.7 - $37.57 $968,994 - $1.6 Million
-42,687 Reduced 76.56%
13,068 $367,000
Q2 2022

Jul 29, 2022
BUY
$20.5 - $37.33 $856,797 - $1.56 Million
41,795 Added 299.39%
55,755 $1.5 Million
Q1 2022

Apr 29, 2022
BUY
$27.64 - $39.32 $107,049 - $152,286
3,873 Added 38.4%
13,960 $475,000
Q4 2021

Feb 07, 2022
SELL
$35.68 - $56.27 $338,496 - $533,833
-9,487 Reduced 48.47%
10,087 $390,000
Q3 2021

Nov 01, 2021
BUY
$28.95 - $55.99 $566,667 - $1.1 Million
19,574 New
19,574 $1.06 Million
Q1 2021

May 13, 2021
SELL
$16.19 - $29.91 $406,417 - $750,830
-25,103 Closed
0 $0
Q4 2020

Feb 04, 2021
BUY
$14.99 - $22.75 $376,293 - $571,093
25,103 New
25,103 $440,000

Others Institutions Holding CLDX

# of Institutions
203
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.15B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email